El adalimumab, etanercept, infliximab, certolizumab pegol y golimumab para el tratamiento de la artritis reumatoide. Revisión de TA130, TA186 y TA225) (ID537)

Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2014
Cargando información sobre las referencias

RECORD STATUS:

This is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available.

CITATION:

Adalimumab, etanercept, infliximab, certolizumab pegol and golimumab for the treatment of rheumatoid arthritis. Review of TA130, TA186 and TA225) (ID537) Health Technology Assessment
Epistemonikos ID: 36ba7cfd5a130bf8329fbd7f498255b1e91143bd
First added on: Feb 06, 2015